GLP-1 Receptor Agonist Use Increases Likelihood of Antidepressant Prescription
Individuals taking glucagon-like peptide (GLP)-1 receptor agonists have a greater risk for subsequently being dispensed antidepressants, according to a study published online April 23 in Diabetes, Obesity, and Metabolism ...
